In-hospital hyperglycemia but not diabetes mellitus alone is associated with increased in-hospital mortality in community-acquired pneumonia (CAP): a systematic review and meta-analysis of observational studies prior to COVID-19
Open Access
- 5 July 2022
- journal article
- review article
- Published by BMJ in BMJ Open Diabetes Research & Care
- Vol. 10 (4) , e002880
Abstract
The objective of this review was to quantify the association between diabetes, hyperglycemia, and outcomes in patients hospitalized for community-acquired pneumonia (CAP) prior to the COVID-19 pandemic by conducting a systematic review and meta-analysis. Two investigators independently screened records identified in the PubMed (MEDLINE), EMBASE, CINAHL, and Web of Science databases. Cohort and case–control studies quantitatively evaluating associations between diabetes and in-hospital hyperglycemia with outcomes in adults admitted to hospital with CAP were included. Quality was assessed using the Newcastle-Ottawa Quality Assessment Scale, effect size using random-effects models, and heterogeneity using I2 statistics. Thirty-eight studies met the inclusion criteria. Hyperglycemia was associated with in-hospital mortality (adjusted OR 1.28, 95% CI 1.09 to 1.50) and intensive care unit (ICU) admission (crude OR 1.82, 95% CI 1.17 to 2.84). There was no association between diabetes status and in-hospital mortality (adjusted OR 1.04, 95% CI 0.72 to 1.51), 30-day mortality (adjusted OR 1.13, 95% CI 0.77 to 1.67), or ICU admission (crude OR 1.91, 95% CI 0.74 to 4.95). Diabetes was associated with increased mortality in all studies reporting >90-day postdischarge mortality and with longer length of stay only for studies reporting crude (OR 1.50, 95% CI 1.11 to 2.01) results. In adults hospitalized with CAP, in-hospital hyperglycemia but not diabetes alone is associated with increased in-hospital mortality and ICU admission. Diabetes status is associated with increased >90-day postdischarge mortality. Implications for management are that in-hospital hyperglycemia carries a greater risk for in-hospital morbidity and mortality than diabetes alone in patients admitted with non-COVID-19 CAP. Evaluation of strategies enabling timely and effective management of in-hospital hyperglycemia in CAP is warranted.Keywords
Funding Information
- Australian Government Research Training Program ScholarshipNA (N/A)
This publication has 52 references indexed in Scilit:
- Impact of admission blood glucose level on outcomes in community-acquired pneumonia in older adultsInternational Journal of General Medicine, 2013
- Predictors for length of hospital stay in patients with community-acquired Pneumonia: Results from a Swiss Multicenter studyBMC Pulmonary Medicine, 2012
- Systematic review of discharge coding accuracyJournal of Public Health, 2011
- The influence of pre-existing diabetes mellitus on the host immune response and outcome of pneumonia: analysis of two multicentre cohort studiesThorax, 2010
- Hyperglycemia in diabetics and non-diabetics: Effect on the risk for and severity of pneumococcal pneumoniaJournal of Infection, 2010
- Fasting hyperglycemia upon hospital admission is associated with higher pneumonia complication rates among the elderlyInternational Archives of Medicine, 2010
- Normal Glucose Values Are Associated With a Lower Risk of Mortality in Hospitalized PatientsDiabetes Care, 2008
- Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemiaBlood, 2008
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Hyperglycemia as a predictor for mortality in veterans with pneumoniaExperimental Aging Research, 1988